List of investigational sleep drugs
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Qwerfjkl (bot) (talk | contribs) at 18:33, 16 March 2022 (Changing short description "Wikipedia list article" to "none" per WP:SDNONE (via Bandersnatch)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:33, 16 March 2022 by Qwerfjkl (bot) (talk | contribs) (Changing short description "Wikipedia list article" to "none" per WP:SDNONE (via Bandersnatch))
This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.
Insomnia
GABAA receptor potentiators
- EVT-201 – GABAA receptor positive allosteric modulator[1]
- Lorediplon (GF-015535-00) – GABAA receptor positive allosteric modulator [2]
- Zuranolone (SAGE-217) – GABAA receptor positive allosteric modulator [3]
Orexin receptor antagonists
- Seltorexant (MIN-202, JNJ,42847922, JNJ-922) – selective OX2 receptor antagonist [4]
- Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2 receptor antagonist [5]
Melatonin receptor agonists
- Piromelatine (Neu-P11) – melatonin receptor agonist and 5-HT1A and 5-HT1D receptor agonist [6]
Nociceptin receptor agonists
- Sunobinop (IMB-115, IT-1315, S-117957, V-117957) – nociceptin receptor agonist [7][8]
Hypersomnia/narcolepsy
Orexin receptor agonists
- Danavorexton (TAK-925) – OX2 receptor-selective agonist via IV infusion[1][9]
- TAK-994 – OX2 receptor agonist pill (orally available) [1]
Monoaminergics
- Flecainide/modafinil (THN-102) – modafinil (dopamine reuptake inhibitor) and flecainide (antiarrhythmic) combination [10]
- Mazindol controlled release (NLS-1001, NLS-1) – norepinephrine-predominant serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI)[11]
- Reboxetine (AXS-12) – norepinephrine reuptake inhibitor (NRI) [12]
GHB receptor agonists
- FT-218 (sodium oxybate controlled release) – GHB and GABAB receptor agonist [13]
GABAA receptor inhibitors
- Pentylenetetrazole (BTD-001) – GABAA receptor negative allosteric modulator [14]
See also
References
Adamantanes | |
---|---|
Adenosine antagonists | |
Alkylamines | |
Ampakines | |
Arylcyclohexylamines | |
Benzazepines | |
Cathinones |
|
Cholinergics |
|
Convulsants | |
Eugeroics | |
Oxazolines | |
Phenethylamines |
|
Phenylmorpholines | |
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams | |
Tropanes |
|
Tryptamines | |
Others |
|